Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: October 2008
-
Law Seminars International (LSI) will be holding a conference on Innovative Strategies for Accelerating the Commercialization of Life Sciences Inventions on January 29-30, 2009 in Phoenix, AZ. During the conference, LSI's faculty will offer presentations on the following topics: • Accelerating the "gap" from discovery to development to commercialization;• Valuation of discoveries from discovery to…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office and USPTO Director Jon Dudas filed their reply brief in the Tafas v. Dudas appeal. On the same day that the Patent Office filed its reply brief, Patently-O provided links to the fifteen amicus briefs filed in the appeal, thirteen of which…
-
By Donald Zuhn — Last week, Immunomedics, Inc. announced that the U.S. Patent and Trademark Office has issued U.S. Patent No. 7,435,803, which is directed to humanized and chimeric anti-CD20 antibodies and CD20 antibody fusion proteins. Such antibodies are useful for the treatment and diagnosis of B-cell disorders, such as B-cell malignancies and autoimmune…
-
By Christopher P. Singer — In a Notice dated October 14, 2008, the U.S. Patent and Trademark Office announced that the Korean Intellectual Property Office (KIPO) has become the third participating foreign intellectual property office in the electronic priority document exchange program. This complements our prior report based on information provided by one of…
-
By Donald Zuhn — Last week, the Federal Circuit affirmed a determination by the Board of Patent Appeals and Interferences that the claims of U.S. Application No. 10/041,958 would have been obvious in view of five prior art references. The '958 application, filed by Appellants Saul Tzipori, Ramaswamy Balakrishnan, and Arthur Donohue-Rolfe (Tzipori), relates…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Zydus Pharmaceuticals, Inc., USA et al. v. Teva Pharmaceutical Industries Ltd et al.1:08-cv-01071; filed October 14, 2008 in the Eastern District of…
-
October 23-24, 2008 – Patent Litigation 2008 (Practising Law Institute) – Chicago, IL October 28-29, 2008 – Pharma/Biotech IP Due Diligence*** (C5) – Amsterdam, Netherlands November 10-11, 2008 – Patent Litigation 2008 (Practising Law Institute) – Atlanta, GA November 11-13, 2008 – 4th Biosimilars conference (Visiongain) – Philadelphia, PA November 12-14, 2008 – Structuring, Negotiating…
-
The Center for Business Intelligence (CBI) will be holding its Bio/Pharmaceutical Summit on Legal and Regulatory Product Lifecycle Strategies on January 20-21, 2009 in Baltimore, MD. The conference will address the current challenges, policies, and practical strategies from both legal and regulatory perspectives to help companies implement a more effective and modern approach to lifecycle…
-
District Court Decision Impacts PTA Determinations By Donald Zuhn — On September 30th, the District Court for the District of Columbia granted summary judgment in favor of Wyeth, determining that the U.S. Patent and Trademark Office had misconstrued 35 U.S.C. § 154(b)(2)(A), and as a result, had denied Wyeth a portion of patent term to…
-
By Donald Zuhn — The U.S. Patent and Trademark Office and USPTO Director Jon Dudas filed their reply brief today in the Tafas v. Dudas appeal (a copy of the brief can be obtained here). We previously reported on the filing of opening appeal briefs by the PTO, GSK, and Dr. Tafas. The Patent Office…
Patent Docs 